Benign prostatic hyperplasia (BPH) -Epidemiology Forecast to 2027

SKU ID : DEL- 10918259

Publishing Date : 01-Jan-2018

No. of pages : 50

PRICE
3250
9750

  • DelveInsight's "Benign prostatic hyperplasia (BPH) - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Benign prostatic hyperplasia (BPH) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027.

    Markets Covered
    • United States
    • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
    • Japan

    Study Period: 2016-2027

    Benign prostatic hyperplasia (BPH) Epidemiology
    The epidemiology section covers the historical, current as well as forecasted epidemiology for Benign prostatic hyperplasia (BPH) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the Benign prostatic hyperplasia (BPH) outlook. It also includes the explanation of changing trends of epidemiology outlining the Benign prostatic hyperplasia (BPH) scenario.

    Benign prostatic hyperplasia (BPH) Epidemiology Segmentation
    The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Benign prostatic hyperplasia (BPH) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

    Report Scope
    • The report covers detailed overview of Benign prostatic hyperplasia (BPH) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
    • It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
    • The Benign prostatic hyperplasia (BPH) Report assesses the disease risk and burden and highlights the unmet needs
    • It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

    Key strengths
    • 10 Year Forecast
    • 7MM Coverage
    • Total Cases in Benign prostatic hyperplasia (BPH)

    Key assessments
    • Patient Segmentation in Benign prostatic hyperplasia (BPH)
    • Benign prostatic hyperplasia (BPH) Risk & Burden
    • Factors driving growth in a specific Benign prostatic hyperplasia (BPH) patient population

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports